June 17, 2020 / 4:48 AM / 21 days ago

BRIEF-Ipsen Obtains FDA's Fast Track designation For ONIVYDE

June 17 (Reuters) - Ipsen SA:

* OBTAINS FAST TRACK DESIGNATION FROM FDA FOR LIPOSOMAL IRINOTECAN (ONIVYDE®) AS COMBINATION TREATMENT FOR METASTATIC PANCREATIC CANCER Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below